Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Alleviant Medical is raising $20,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Adam Berman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Alleviant Medical

Alleviant Medical is developing next-generation devices to lift the burden of heart failure. Alleviant Medical is a medical device company developing potential therapies for congestive heart failure.

To learn more about Alleviant Medical, visit http://www.alleviantmedical.com/

Contact:
Adam Berman, Chief Executive Officer
857-776-2154
https://www.linkedin.com/in/adamlberman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved